๐ฐ Mini Symposium Session News
Mini Symposium Session News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mini Symposium Session. Real-time updates on events, politics, business and more.
April 18, 2023
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & SAN MATEO, Calif. & STAMFORD, Conn.--(BUSINESS WIRE)--MapKure, LLC, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), today announced that they will present updated clinical data from the Phase 1a/1b study of B...
April 18, 2023
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & STAMFORD, Conn.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), today announced that they will present updated clinical data from the Phase 1b trial of BeiGeneโs RAF dimer inhibitor, lifiraf...
April 17, 2023
MapKure, LLC, BeiGene, Ltd. , and SpringWorks Therapeutics, Inc. , today announced that they will present updated clinical data from the Phase 1a/1b study of BGB-3245, an investigational, selective... | April 17, 2023
April 17, 2023
BeiGene, Ltd. , and SpringWorks Therapeutics, Inc. , today announced that they will present updated clinical data from the Phase 1b trial of BeiGene’s RAF dimer inhibitor, lifirafenib, in... | April 17, 2023
April 17, 2023
STAMFORD, Conn. and BASEL, Switzerland and BEIJING and CAMBRIDGE, Mass. and SAN MATEO, Calif., April 17, 2023 -- MapKure, LLC, SpringWorks Therapeutics, Inc. , and BeiGene, Ltd. , today... | April 17, 2023
April 17, 2023
STAMFORD, Conn. and BASEL, Switzerland and BEIJING and CAMBRIDGE, Mass., April 17, 2023 -- SpringWorks Therapeutics, Inc. , and BeiGene, Ltd. , today announced that they will present updated... | April 17, 2023